| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |